{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:19:57Z","timestamp":1790252397934,"version":"4.1.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"vor","delay-in-days":2375,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["slas-technology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Technology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1177\/2211068214563794","type":"journal-article","created":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T01:49:23Z","timestamp":1421891363000},"page":"519-538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Diagnosis and Management of Hepatitis C Virus Infection"],"prefix":"10.1016","volume":"20","author":[{"given":"Ronita","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Rodden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manita","family":"Chaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikitha","family":"Bollipalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Niemz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1177\/2211068214563794_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C Virus Infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1177\/2211068214563794_bib2","unstructured":"World Health Organization. Hepatitis C. http:\/\/www.who.int\/csr\/disease\/hepatitis\/whocdscsrlyo2003\/en\/index7.html (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, Management, and Treatment of Hepatitis C: An Update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology."},{"key":"10.1177\/2211068214563794_bib4","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1086\/646614","article-title":"Peripheral CXCR3-Associated Chemokines as Biomarkers of Fibrosis in Chronic Hepatitis C Virus Infection","volume":"200","author":"Zeremski","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1177\/2211068214563794_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0168-8278(97)80409-6","article-title":"Serum Interleukin 4 and Interleukin 10 Levels in Patients with Chronic Hepatitis C Virus Infection","volume":"26","author":"Reiser","year":"1997","journal-title":"J. Hepatol."},{"key":"10.1177\/2211068214563794_bib6","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology."},{"key":"10.1177\/2211068214563794_bib7","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(03)15109-4","article-title":"Viral Hepatitis C","volume":"362","author":"Poynard","year":"2003","journal-title":"Lancet."},{"key":"10.1177\/2211068214563794_bib8","first-page":"1","article-title":"Recommendations for the Identification of Chronic Hepatitis C Virus Infection among Persons Born during 1945\u20131965","volume":"61","author":"Smith","year":"2012","journal-title":"MMWR Recomm. Rep."},{"issue":"2","key":"10.1177\/2211068214563794_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2893.1997.tb00178.x","article-title":"The Role of Immune Responses in the Pathogenesis of Hepatitis C Virus Infection","volume":"4","author":"Koziel","year":"1997","journal-title":"J. Viral Hepat."},{"key":"10.1177\/2211068214563794_bib10","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global Epidemiology of Hepatitis C Virus Infection: New Estimates of Age-Speci\ufb01c Antibody to HCV Seroprevalence","volume":"57","author":"Hana\ufb01ah","year":"2013","journal-title":"Hepatology."},{"key":"10.1177\/2211068214563794_bib11","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMra1213651","article-title":"Current and Future Therapies for Hepatitis C Virus Infection","volume":"368","author":"Liang","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1177\/2211068214563794_bib12","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1002\/hep.1840360709","article-title":"Use and Interpretation of Virological Tests for Hepatitis C","volume":"36","author":"Pawlotsky","year":"2002","journal-title":"Hepatology."},{"key":"10.1177\/2211068214563794_bib13","first-page":"362","article-title":"Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians","volume":"62","year":"2013","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1177\/2211068214563794_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3350\/cmh.2013.19.4.376","article-title":"Predicting Factors of Present Hepatitis C Virus Infection among Patients Positive for the Hepatitis C Virus Antibody","volume":"19","author":"Lee","year":"2013","journal-title":"Clin. Molec. Hepatol."},{"key":"10.1177\/2211068214563794_bib15","unstructured":"Kaplan, M. M., Bonis, P. A. Histologic Scoring Systems for Chronic Liver Disease. http:\/\/www.uptodate.com\/contents\/histologic-scoring-systems-for-chronic-liver-disease (Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib16","first-page":"81","article-title":"Operational Scores in the Diagnosis of Chronic Hepatitis: A Semi-Quantitative Assessment","volume":"53","author":"Stanculet","year":"2012","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1177\/2211068214563794_bib17","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient Elastography: A New Noninvasive Method for Assessment of Hepatic Fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med. Biol."},{"key":"10.1177\/2211068214563794_bib18","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.3748\/wjg.v20.i13.3431","article-title":"Tools for the Diagnosis of Hepatitis C Virus Infection and Hepatic Fibrosis Staging","volume":"20","author":"Saludes","year":"2014","journal-title":"World J. Gastroent.: WJG."},{"key":"10.1177\/2211068214563794_bib19","unstructured":"Subramanian, V., Bharat, A., Vachharajani, N., et al. Perioperative Blood Transfusion Affects Hepatitis C Virus (HCV)-Specific Immune Responses and Outcome following Liver Transplantation in HCV-Infected Patients. HPB (Oxford). 2013, 1\u201313."},{"key":"10.1177\/2211068214563794_bib20","first-page":"1","article-title":"Low Hepatitis C Viral Load Predicts Better Long-Term Outcomes in Patients Undergoing Resection of Hepatocellular Carcinoma Irrespective of Serologic Eradication of Hepatitis C Virus","volume":"30","author":"Shindoh","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1177\/2211068214563794_bib21","first-page":"560","article-title":"Evaluation of CXCL10 as a Novel Serum Marker for Predicting Liver Metastasis and Prognosis in Colorectal Cancer","volume":"40","author":"Toiyama","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1177\/2211068214563794_bib22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.510260603","article-title":"Clinical, Histological, and Virological Features of Hepatitis C Virus Carriers with Persistently Normal or Abnormal Alanine Transaminase Levels","volume":"26","author":"Puoti","year":"1997","journal-title":"Hepatology."},{"key":"10.1177\/2211068214563794_bib23","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/507307","article-title":"Interferon (IFN)-Gamma-Inducible Protein-10: Association with Histological Results, Viral Kinetics, and Outcome during Treatment with Pegylated IFN-Alpha 2a and Ribavirin for Chronic Hepatitis C Virus Infection","volume":"194","author":"Romero","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1177\/2211068214563794_bib24","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/hep.21407","article-title":"IP-10 Predicts Viral Response and Therapeutic Outcome in Difficult-to-Treat Patients with HCV Genotype 1 Infection","volume":"44","author":"Lagging","year":"2006","journal-title":"Hepatology."},{"key":"10.1177\/2211068214563794_bib25","unstructured":"Teitel A. D. Complement Component 3 (C3). http:\/\/www.nlm.nih.gov\/medlineplus\/ency\/article\/003539.htm (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib26","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/pmic.200500488","article-title":"Identification of Complement C3a as a Candidate Biomarker in Human Chronic Hepatitis C and HCV-Related Hepatocellular Carcinoma Using a Proteomics Approach","volume":"6","author":"Lee","year":"2006","journal-title":"Proteomics."},{"key":"10.1177\/2211068214563794_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-5926-4-6","article-title":"Accuracy of Hyaluronic Acid Level for Predicting Liver Fibrosis Stages in Patients with Hepatitis C Virus","volume":"4","author":"Halfon","year":"2005","journal-title":"Comp. Hepatol."},{"key":"10.1177\/2211068214563794_bib28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/1471-2334-13-399","article-title":"S. Human Immunodeficiency Virus, Hepatitis C, and Inflammatory Biomarkers in Individuals with Alcohol Problems: A Cross-Sectional Study","volume":"13","author":"Armah","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1177\/2211068214563794_bib29","article-title":"Serum Hyaluronic Acid and Laminin as Biomarkers in Liver Fibrosis","volume":"19","author":"Parsian","year":"2010","journal-title":"J. Gastrointest. & Liver Dis."},{"key":"10.1177\/2211068214563794_bib30","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1373\/clinchem.2005.048389","article-title":"Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection","volume":"51","author":"Adams","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1177\/2211068214563794_bib31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical Markers of Liver Fibrosis in Patients with Hepatitis C Virus Infection: A Prospective Study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet."},{"key":"10.1177\/2211068214563794_bib32","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1111\/j.1572-0241.1998.00703.x","article-title":"Serum Alpha-Fetoprotein Levels and Liver Histology in Patients with Chronic Hepatitis C","volume":"93","author":"Bayati","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"10.1177\/2211068214563794_bib33","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.24131","article-title":"Insurance Status and Treatment Candidacy of Hepatitis C Patients: Analysis of Population-Based Data from the United States","volume":"53","author":"Stepanova","year":"2011","journal-title":"Hepatology."},{"issue":"1","key":"10.1177\/2211068214563794_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2013.08.028","article-title":"Antisense Therapy for Hepatitis C Virus Infection","volume":"60","author":"de Jong","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1177\/2211068214563794_bib35","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1099\/0022-1317-74-11-2391","article-title":"Classification of Hepatitis C Virus into Six Major Genotypes and a Series of Subtypes by Phylogenetic Analysis of the NS-5 Region","volume":"74","author":"Yap","year":"1993","journal-title":"J. Gen. Virol."},{"key":"10.1177\/2211068214563794_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7150\/ijms.3.41","article-title":"Epidemiology of Hepatitis C Virus (HCV) Infection","volume":"3","author":"Sy","year":"2006","journal-title":"Int. J. Med. Sci."},{"key":"10.1177\/2211068214563794_bib37","first-page":"323","article-title":"Geographical Distribution of Hepatitis C Virus Genotypes in India","volume":"45","author":"Das","year":"2002","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1177\/2211068214563794_bib38","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1128\/jcm.33.6.1679-1681.1995","article-title":"Genotyping of Hepatitis C Virus in South Africa","volume":"33","author":"Smuts","year":"1995","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1177\/2211068214563794_bib39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2210-7401(11)70007-9","article-title":"Antiviral Activity of the New DAAs for the Treatment of Hepatitis C Virus Infection: Virology and Resistance","volume":"35","author":"Chevaliez","year":"2011","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1177\/2211068214563794_bib40","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1128\/JVI.79.4.2346-2355.2005","article-title":"Ribavirin Resistance in Hepatitis C Virus Replicon-Containing Cell Lines Conferred by Changes in the Cell Line or Mutations in the Replicon RNA","volume":"79","author":"Pfeiffer","year":"2005","journal-title":"J. Virol."},{"issue":"7","key":"10.1177\/2211068214563794_bib41","first-page":"377","article-title":"Treatment of Hepatitis C Monoinfection in Adults: Dutch National Guidelines","volume":"71","author":"Lamers","year":"2013","journal-title":"Neth. J. Med."},{"key":"10.1177\/2211068214563794_bib42","unstructured":"Santaris Pharma A\/S. Miravirsen in Combination with Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha plus Ribavirin Subjects with Chronic Hepatitis C Virus Infection. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01872936 (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib43","doi-asserted-by":"crossref","first-page":"e34548","DOI":"10.1371\/journal.pone.0034548","article-title":"Treatment of Hepatitis C as Prevention: A Modeling Case Study in Vietnam","volume":"7","author":"Durier","year":"2012","journal-title":"PloS ONE."},{"key":"10.1177\/2211068214563794_bib44","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/cid\/ciu066","article-title":"Effectiveness and Cost-Effectiveness of Immediate versus Delayed Treatment of Hepatitis C Virus-Infected Patients in a Country with Limited Resources: The Case of Egypt","volume":"58","author":"Obach","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1177\/2211068214563794_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nbt0114-3","article-title":"FDA Approvals Usher in the Post-Interferon Era in HCV","volume":"32","author":"Sheridan","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1177\/2211068214563794_bib46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nbt0614-501","article-title":"Sovaldi Makes Blockbuster History, Ignites Drug Pricing Unrest","volume":"32","author":"Senior","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1177\/2211068214563794_bib47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/523585","article-title":"Rapid Virologic Response: A New Milestone in the Management of Chronic Hepatitis C","volume":"46","author":"Poordad","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1177\/2211068214563794_bib48","unstructured":"Kim, N. H., Spach, D. H. Virologic Responses during Treatment of Hepatitis C. http:\/\/depts.washington.edu\/hepstudy\/hepC\/mgmt\/viroresponse\/index.shtml (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib49","series-title":"Telaprevir: Package Insert.","year":"2011"},{"key":"10.1177\/2211068214563794_bib50","series-title":"VICTRELIS\u2122 (Boceprevir) Capsules: Package Insert","year":"2011"},{"key":"10.1177\/2211068214563794_bib51","unstructured":"US Food and Drug Administration. CLIA Waivers. http:\/\/www.fda.gov\/MedicalDevices\/DeviceRegulationandGuidance\/IVDRegulatoryAssistance\/ucm124105.htm (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7150\/ijms.3.35","article-title":"Hepatitis C Virus Serologic and Virologic Tests and Clinical Diagnosis of HCV-Related Liver Disease","volume":"3","author":"Chevaliez","year":"2006","journal-title":"Int. J. Med. Sci."},{"key":"10.1177\/2211068214563794_bib53","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1002\/hep.510260708","article-title":"Diagnostic Tests for Hepatitis C","volume":"26","author":"Gretch","year":"1997","journal-title":"Hepatology."},{"key":"10.1177\/2211068214563794_bib54","unstructured":"Ortho. Clinical Hepatitis C Virus Encoded Antigen (Recombinant c22-3, c200 and NS5) ORTHO\u00ae HCV Version 3.0 ELISA Test System. http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/LicensedProductsBLAs\/BloodDonorScreening\/InfectiousDisease\/UCM176421.pdf (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib55","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1743-422X-9-290","article-title":"Performance and Diagnostic Usefulness of Commercially Available Enzyme Linked Immunosorbent Assay and Rapid Kits for Detection of HIV, HBV and HCV in India","volume":"9","author":"Maity","year":"2012","journal-title":"Virol. J."},{"key":"10.1177\/2211068214563794_bib56","first-page":"35","article-title":"Specificity and Sensitivity of 3rd Generation EIA for Detection of HCV Antibodies among Intravenous Drug-Users","volume":"16","author":"Filice","year":"1993","journal-title":"New Microbiol."},{"key":"10.1177\/2211068214563794_bib57","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1128\/JCM.01603-08","article-title":"Clinical Performance Evaluation of Four Automated Chemiluminescence Immunoassays for Hepatitis C Virus Antibody Detection","volume":"46","author":"Kim","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jmv.10209","article-title":"Evaluation of the Clinical Usefulness of COBAS AMPLICOR HCV MONITOR Assay (ver. 2.0): Comparison with AMPLICOR HCV MONITOR Assay (ver. 1.0) and HCV Core Protein Level","volume":"68","author":"Kawai","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1177\/2211068214563794_bib59","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jcla.20119","article-title":"Evaluation of the Ortho-Clinical Diagnostics VITROS ECi Anti-HCV Test: Comparison with Three Other Methods","volume":"21","author":"Watterson","year":"2007","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1177\/2211068214563794_bib60","unstructured":"VITROS. VITROS Immunodiagnostic Products. http:\/\/www.cdc.gov\/NCHS\/data\/nhanes\/nhanes_09_10\/HEPC_F_met_hepc.pdf (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib61","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/cid\/cis368","article-title":"Laboratory Diagnostics for Hepatitis C Virus Infection","volume":"1","author":"Kamili","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1177\/2211068214563794_bib62","unstructured":"Ortho. Clinical Evaluation of Antibody to Hepatitis C Virus (Anti-HCV) Assay on VITROS 5600 Integrated System. http:\/\/www.orthoclinical.com\/en-us\/Documents\/VITROS%20Posters%202009\/CL11155%20HepC_PstrBk.pdf (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib63","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1128\/JCM.01856-09","article-title":"New Automated Hepatitis C Virus (HCV) Core Antigen Assay as an Alternative to Real-Time PCR for HCV RNA Quantification","volume":"48","author":"Park","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib64","first-page":"75","article-title":"Performance of a New Hepatitis C Assay on the Bayer ADVIA Centaur Immunoassay System","volume":"50","author":"Denoyel","year":"2004","journal-title":"Clin. Lab."},{"issue":"20","key":"10.1177\/2211068214563794_bib65","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.5897\/AJMR2013.5391","article-title":"Ortho VITROS Enhanced Chemiluminescence Assay for Detection of Hepatitis C Virus (HCV) Antibodies: Determination of a \u201cBorderline\u201d Range","volume":"7","author":"Petruzziello","year":"2013","journal-title":"African J. Microbiol. Res."},{"key":"10.1177\/2211068214563794_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4038\/sljid.v3i2.5172","article-title":"Diagnostic Efficacy of Rapid Assays Used for the Detection of Hepatitis B Virus Surface Antigen","volume":"3","author":"Chameera","year":"2013","journal-title":"Sri Lankan J. Infectious Dis."},{"issue":"6","key":"10.1177\/2211068214563794_bib67","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/infdis\/jir422","article-title":"Evaluation of Three Rapid Screening Assays for Detection of Antibodies to Hepatitis C Virus","volume":"204","author":"Smith","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1177\/2211068214563794_bib68","unstructured":"Tulipgroup. Combiquic (HIV \/ HCV) Rapid Immuno-concentration Assay for Detection of Antibodies to HIV1\/2 and HCV in Human Plasma\/Serum. http:\/\/www.tulipgroup.com\/Qualpro_New\/qrg\/Combiquic%20HIV%20HCV.pdf (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib69","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jcv.2007.11.002","article-title":"Sensitivity of a Rapid Immuno-Chromatographic Test for Hepatitis C Antibodies Detection","volume":"41","author":"Desbois","year":"2008","journal-title":"J. Clin. Virol."},{"key":"10.1177\/2211068214563794_bib70","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1537-2995.2012.03770.x","article-title":"Laboratory Evaluation of Rapid Test Kits to Detect Hepatitis C Antibody for Use in Predonation Screening in Emergency Settings","volume":"53","author":"O\u2019Connell","year":"2013","journal-title":"Transfusion."},{"key":"10.1177\/2211068214563794_bib71","unstructured":"OraQuick. Step-by-Step Instructions for OraQuick\u00ae HCV Rapid Antibody Test. http:\/\/www.hcvadvocate.org\/hepatitis\/factsheets_pdf\/OraQuick_HCV_Rapid_Antibody_Test.pdf (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib72","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3343\/alm.2013.33.3.184","article-title":"Performance Evaluation of the OraQuick Hepatitis C Virus Rapid Antibody Test","volume":"33","author":"Cha","year":"2013","journal-title":"Annals Lab. Med."},{"key":"10.1177\/2211068214563794_bib73","unstructured":"OraQuick. OraQuick HCV Product Training. http:\/\/www.ndhealth.gov\/disease\/Hepatitis\/Training\/2012%20Symposium%20Presentations\/HCV%20Customer%20Training%20Presentation.pdf (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib74","unstructured":"World Health Organization. Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection. http:\/\/apps.who.int\/iris\/bitstream\/10665\/111747\/1\/9789241548755_eng.pdf?ua=1&ua=1 (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib75","unstructured":"Beckman Coulter. Beckman Coulter: Synchron System AST Reagent Package Insert. https:\/\/www.beckmancoulter.com\/wsrportal\/techdocs?docname=\/cis\/A18460\/AG\/EN_AST.pdf (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib76","unstructured":"VITROS. VITROS Chemistry Products ALT Slides Package Insert. http:\/\/www.cmmc.org\/cmmclab\/IFU\/ALT_050.PDF (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib77","unstructured":"VITROS. VITROS Chemistry Products AST Slides Package Insert. http:\/\/www.cmmc.org\/cmmclab\/IFU\/AST_060.PDF (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib78","doi-asserted-by":"crossref","first-page":"152ra129","DOI":"10.1126\/scitranslmed.3003981","article-title":"A Paper-Based Multiplexed Transaminase Test for Low-Cost, Point-of-Care Liver Function Testing","volume":"4","author":"Pollock","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1177\/2211068214563794_bib79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0399-8320(08)73991-5","article-title":"FibroTest-ActiTest as a Non-Invasive Marker of Liver Fibrosis","volume":"32","author":"Halfon","year":"2008","journal-title":"Gastroent\u00e9rologie clinique et biologique."},{"key":"10.1177\/2211068214563794_bib80","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1373\/clinchem.2006.070961","article-title":"A Prospective Analysis of the Prognostic Value of Biomarkers (FibroTest) in Patients with Chronic Hepatitis C","volume":"52","author":"Ngo","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1177\/2211068214563794_bib81","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1572-0241.2006.00411.x","article-title":"Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest\u2013Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study","volume":"101","author":"Halfon","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1177\/2211068214563794_bib82","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1373\/clinchem.2004.032227","article-title":"Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C","volume":"50","author":"Poynard","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1177\/2211068214563794_bib83","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1440-1746.2009.05778.x","article-title":"An Evaluation of the Potential Cost-Effectiveness of Non-Invasive Testing Strategies in the Diagnosis of Significant Liver Fibrosis","volume":"24","author":"Carlson","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1177\/2211068214563794_bib84","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.22509","article-title":"Treating Hepatitis C in the Prison Population Is Cost-Saving","volume":"48","author":"Tan","year":"2008","journal-title":"Hepatology."},{"key":"10.1177\/2211068214563794_bib85","doi-asserted-by":"crossref","first-page":"e26783","DOI":"10.1371\/journal.pone.0026783","article-title":"Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients","volume":"6","author":"Liu","year":"2011","journal-title":"PloS ONE."},{"key":"10.1177\/2211068214563794_bib86","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1128\/JCM.38.11.4171-4179.2000","article-title":"Improved Version 2.0 Qualitative and Quantitative AMPLICOR Reverse Transcription-PCR Tests for Hepatitis C Virus RNA: Calibration to International Units, Enhanced Genotype Reactivity, and Performance Characteristics","volume":"38","author":"Lee","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib87","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1128\/JCM.02004-12","article-title":"The Cobas AmpliPrep\/Cobas TaqMan HCV Test, Version 2.0, Real-Time PCR Assay Accurately Quantifies Hepatitis C Virus Genotype 4 RNA","volume":"51","author":"Chevaliez","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib88","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1537-2995.2007.01343.x","article-title":"Comparison of Two Automated Nucleic Acid Testing Systems for Simultaneous Detection of Human Immunodeficiency Virus and Hepatitis C Virus RNA and Hepatitis B Virus DNA","volume":"47","author":"Margaritis","year":"2007","journal-title":"Transfusion."},{"key":"10.1177\/2211068214563794_bib89","unstructured":"Roche. Molecular Evolution of Molecular Testing: Introducing Absolute Automation Cobas\u00ae 6800\/8800 Systems. http:\/\/www.roche-diagnostics.ch\/content\/dam\/corporate\/roche-dia_ch\/documents\/broschueren\/molecular_diagnostics\/new_gen\/EN_EA_cobas-6800_8800_Flyer.pdf (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib90","unstructured":"Roche. Roche Launches New Fully Automated Molecular Diagnostic Systems Offering the Fastest Time to Results with the Highest Testing Capacity. http:\/\/www.roche.com\/media\/media_releases\/med-cor-2014-09-02.htm (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib91","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1128\/JCM.05874-11","article-title":"Performance of the Novel Qiagen Artus QS-RGQ Viral Load Assays Compared to That of the Abbott RealTime System with Genetically Diversified HIV and Hepatitis C Virus Plasma Specimens","volume":"50","author":"Drexler","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib92","unstructured":"Muir, D., Nutter, P., Yao, J., et al. Multicentre Performance Evaluation of the VERSANT\u00ae HCV RNA 1.0 Assay (kPCR) in Quantitative Detection of Hepatitis C Viral RNA. 22nd European Congress of Clinical Microbiology and Infectious Diseases, London, Mar 31\u2013Apr 3, 2012."},{"key":"10.1177\/2211068214563794_bib93","unstructured":"Hologic. Package Insert: APTIMA\u00ae HCV RNA Qualitative Assay. http:\/\/www.hologic.com\/products\/clinical-diagnostics-blood-screening\/assays-and-tests\/aptima-hcv-rna-qualitative-assay (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib94","unstructured":"Hololgic: Panther systems - products link. http:\/\/www.hologic.com\/products\/clinical-diagnostics-and-blood-screening\/instrument-systems\/panther-system (accessed Dec 18, 2014)."},{"key":"10.1177\/2211068214563794_bib95","unstructured":"Gen-Probe Incorporated - Product Pipeline Analysis, 2014 Update. Market Reports Online. http:\/\/www.marketreportsonline.com\/336364.html (accessed Dec 18, 2014)."},{"key":"10.1177\/2211068214563794_bib96","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/JCM.44.3.729-737.2006","article-title":"Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5","volume":"44","author":"Sarrazin","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib97","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/JCM.01784-12","article-title":"Second-Generation Cobas AmpliPrep\/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: A Novel Dual-Probe Assay Design","volume":"51","author":"Zitzer","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib98","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1073\/pnas.88.16.7276","article-title":"Detection of Specific Polymerase Chain-Reaction Product by Utilizing the 5\u2032-]3\u2032 Exonuclease Activity of Thermus-Aquaticus DNA-Polymerase","volume":"88","author":"Holland","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1177\/2211068214563794_bib99","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0378-1119(90)90145-H","article-title":"Use of Uracil DNA Glycosylase to Control Carry-Over Contamination in Polymerase Chain Reactions","volume":"93","author":"Longo","year":"1990","journal-title":"Gene."},{"key":"10.1177\/2211068214563794_bib100","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/JCM.00163-06","article-title":"Real-Time PCR Assays for Hepatitis C Virus (HCV) RNA Quantitation Are Adequate for Clinical Management of Patients with Chronic HCV Infection","volume":"44","author":"Halfon","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib101","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1128\/JCM.40.7.2408-2419.2002","article-title":"Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA","volume":"40","author":"Giachetti","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib102","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0168-8278(96)80115-2","article-title":"Serum HCV RNA Levels Assessed by Quantitative NASBA\u00ae: Stability of Viral Load over Time, and Lack of Correlation with Liver Disease","volume":"25","author":"Hollingsworth","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1177\/2211068214563794_bib103","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00705-011-1001-4","article-title":"Detection of Hepatitis C Virus by an Improved Loop-Mediated Isothermal Amplification Assay","volume":"156","author":"Yang","year":"2011","journal-title":"Arch. Virol."},{"key":"10.1177\/2211068214563794_bib104","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1574-695X.2011.00828.x","article-title":"Rapid Detection of Hepatitis C Virus RNA by a Reverse Transcription Loop-Mediated Isothermal Amplification Assay","volume":"63","author":"Wang","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1177\/2211068214563794_bib105","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/clinchem\/35.8.1588","article-title":"Assay Formats Involving Acridinium-Ester-Labeled DNA Probes","volume":"35","author":"Arnold","year":"1989","journal-title":"Clin. Chem."},{"key":"10.1177\/2211068214563794_bib106","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s13337-012-0067-2","article-title":"Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Hepatitis C Virus","volume":"23","author":"Kargar","year":"2012","journal-title":"Indian J. Virol."},{"key":"10.1177\/2211068214563794_bib107","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1093\/nar\/28.12.e63","article-title":"Loop-Mediated Isothermal Amplification of DNA","volume":"28","author":"Notomi","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1177\/2211068214563794_bib108","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1423-0410.2010.01434.x","article-title":"World Health Organization Collaborative Study to Calibrate the 3rd International Standard for Hepatitis C Virus RNA Nucleic Acid Amplification Technology (NAT)-Based Assays","volume":"100","author":"Baylis","year":"2011","journal-title":"Vox Sang."},{"key":"10.1177\/2211068214563794_bib109","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jcv.2013.09.005","article-title":"Genotype Impact on HCV RNA Levels Determined with the VERSANT HCV RNA 1.0 Assay (kPCR)","volume":"58","author":"Kessler","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1177\/2211068214563794_bib110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/CMR.13.2.223","article-title":"Clinical Significance of Hepatitis C Virus Genotypes","volume":"13","author":"Zein","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1177\/2211068214563794_bib111","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/JCM.02366-06","article-title":"Use of Sequence Analysis of the NS5B Region for Routine Genotyping of Hepatitis C Virus with Reference to C\/E1 and 5\u2032 Untranslated Region Sequences","volume":"45","author":"Murphy","year":"2007","journal-title":"J. Clin. Microbiol."},{"issue":"10","key":"10.1177\/2211068214563794_bib112","article-title":"Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice","volume":"4","author":"Chevaliez","year":"2009","journal-title":"PLoS ONE."},{"key":"10.1177\/2211068214563794_bib113","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1128\/JCM.02463-05","article-title":"Analysis of the 5\u2032 Noncoding Region versus the NS5b Region in Genotyping Hepatitis C Virus Isolates from Blood Donors in France","volume":"44","author":"Cantaloube","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib114","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/clinchem\/48.12.2147","article-title":"Hepatitis C Genotype Determination by Melting Curve Analysis with a Single Set of Fluorescence Resonance Energy Transfer Probes","volume":"48","author":"Bullock","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1177\/2211068214563794_bib115","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/JCM.41.10.4855-4857.2003","article-title":"Evaluation of the TRUGENE HCV 5\u2032 NC Genotyping Kit with the New GeneLibrarian Module 3.1. 2 for Genotyping of Hepatitis C Virus from Clinical Specimens","volume":"41","author":"Germer","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib116","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2893.2002.00362.x","article-title":"Performance of TRUGENE\u2122 Hepatitis C Virus 5\u2032 Noncoding Genotyping Kit, a New CLIP\u2122 Sequencing-Based Assay for Hepatitis C Virus Genotype Determination","volume":"9","author":"Roque-Afonso","year":"2002","journal-title":"J. Viral Hepat."},{"key":"10.1177\/2211068214563794_bib117","unstructured":"US Food and Drug Administration. Abbott RealTime HCV Genotype II: Summary of Safety and Effectiveness Data. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf12\/P120012b.pdf (accessed Dec 6, 2014)."},{"key":"10.1177\/2211068214563794_bib118","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jviromet.2010.03.017","article-title":"A Multicenter Evaluation of the Abbott RealTime HCV Genotype II Assay","volume":"167","author":"Ciotti","year":"2010","journal-title":"J. Virol. Meth."},{"key":"10.1177\/2211068214563794_bib119","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1128\/JCM.01982-06","article-title":"Improvement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV Assay","volume":"45","author":"Bouchardeau","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib120","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/JCM.02390-07","article-title":"Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0","volume":"46","author":"Verbeeck","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib121","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1128\/JCM.00586-13","article-title":"Sequencing Assays for Failed Genotyping with the Versant Hepatitis C Virus Genotype Assay (LiPA), Version 2.0","volume":"51","author":"Larrat","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib122","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1128\/JCM.01249-12","article-title":"Performance of the Abbott RealTime HCV Genotype II RUO Assay","volume":"50","author":"Shinol","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1177\/2211068214563794_bib123","unstructured":"World Health Organization. Low-Cost Tools for Diagnosing and Monitoring HIV Infection in Low-Resource Settings. http:\/\/www.who.int\/bulletin\/volumes\/90\/12\/12-102780\/en\/ (accessed 11\/11, 2014)."},{"key":"10.1177\/2211068214563794_bib124","series-title":"Hepatitis C Test Kit Evaluations.","year":"2001"},{"key":"10.1177\/2211068214563794_bib125","doi-asserted-by":"crossref","first-page":"558","DOI":"10.7326\/0003-4819-157-8-201210160-00006","article-title":"Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis CA Systematic Review and Meta-Analysis","volume":"157","author":"Shivkumar","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1177\/2211068214563794_bib126","unstructured":"M\u00e9decins Sans Fronti\u00e8res. The Diagnosis and Treatment of Hepatitis C: A Technical Landscape. Access Campaign. 2013, 1\u201384."},{"key":"10.1177\/2211068214563794_bib127","unstructured":"World Health Organization (WHO). Organization List of Diagnostics Eligible to Tender for Procurement by WHO in 2014 (including WHO Prequalified Diagnostics). May 15, 2014. http:\/\/www.who.int\/diagnostics_laboratory\/procurement\/140826_v13_pqed_products_eligible_for_procur_2014.pdf (accessed Dec 6, 2014)."}],"container-title":["SLAS Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472630322014996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472630322014996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:00:49Z","timestamp":1762862449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472630322014996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":127,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S2472630322014996"],"URL":"https:\/\/doi.org\/10.1177\/2211068214563794","relation":{},"ISSN":["2472-6303"],"issn-type":[{"value":"2472-6303","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Hepatitis C Virus Infection","name":"articletitle","label":"Article Title"},{"value":"SLAS Technology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1177\/2211068214563794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Society for Laboratory Automation and Screening. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}